The aberrant activation of the cyclin-dependent kinase 4/cyclin D1 pathway is reported frequently in pancreatic cancer due to the overexpression of D-type cyclin proteins [41]. The gene discussed is CDK4; the disease is familial pancreatic carcinoma.